cancer clinical trials in detroit, MI
Wayne State University
Trial Locations Wayne State University Saint John Hospital and Medical Center Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Neuroblastoma
|
Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan 48202 Prostate Cancer
|
Saint John Hospital and Medical Center
Detroit, Michigan 48236 Neuroendocrine Carcinoma
|
Pfizer Investigational Site
Detroit, Michigan 48201 Chronic Myeloid Leukemia
|
Henry Ford Health System, Josephine Ford Cancer Center
Detroit, Michigan 48202 NSCLC
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Adult Nasal Type Extranodal NK/T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult Non-Hodgkin Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult Non-Hodgkin Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
|
Henry Ford Health System
Detroit, Michigan 48202 Prostate Cancer
|
Pfizer Investigational Site
Detroit, Michigan 48201 Systemic Anaplastic Large-Cell Lymphoma, Neoplasms, Anaplastic Lymphoma Kinase, Human, NSCLC
|
Pfizer Investigational Site
Detroit, Michigan 48201 Adenomatous Polyposis Coli
|
Saint John Hospital and Medical Center
Detroit, Michigan 48236 Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
Wayne State University
Trial Locations Wayne State University Saint John Hospital and Medical Center Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
|
Wayne State University
Detroit, Michigan 48202 Stage IV Pancreatic Cancer
|
Henry Ford Hospital Transplant Institute
Detroit, Michigan 48202 Liver Transplantation
|
Wayne State University
Detroit, Michigan 48202 Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer, Thyroid Gland Medullary Carcinoma
|
Henry Ford Hospital
Detroit, Michigan 48202 Breast Cancer
|
Henry Ford Hospital
Detroit, Michigan 48202 Dysphagia
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Lung Cancer
|
Henry Ford Hospital
Trial Locations Henry Ford Hospital Wayne State University School of Medicine Aspergillosis, Invasive Fungal Infections
|
Saint John Hospital and Medical Center
Detroit, Michigan 48236 Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
|
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan 48201 Bladder Cancer
|
Wayne State University
Detroit, Michigan 48202 Childhood Atypical Teratoid/Rhabdoid Tumor
|
Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan 48202 Esophageal Cancer
|
Wayne State University
Trial Locations Wayne State University Saint John Hospital and Medical Center Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
|
Pfizer Investigational Site
Detroit, Michigan 48201 Human Immunodeficiency Virus
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Leukemia
|
Pfizer Investigational Site
Detroit, Michigan 48201 Kidney Neoplasms
|
Wayne State University
Detroit, Michigan 48202 Malignant Neoplasm
|
Saint John Hospital and Medical Center
Detroit, Michigan 48236 HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
Barbara Ann Karmanos Cancer Institute
Trial Locations Barbara Ann Karmanos Cancer Institute Josephine Ford Cancer Center at Henry Ford Hospital Colorectal Cancer
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Retinoblastoma
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
|
Children's Hospital of Michigan
Detroit, Michigan 48201 Acute Myeloid Leukemia
|
Henry Ford Health System
Detroit, Michigan 48202 Glioblastoma Multiforme
|
Henry Ford Health System
Detroit, Michigan 48202 Thyroid Cancer
|
Wayne State University
Detroit, Michigan 48202 Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
|
Henry Ford Hospital
Detroit, Michigan 48202 Deep Vein Thrombosis, Pulmonary Embolism
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Multiple Myeloma, Renal Insufficiency
|
1200.36.0003 Boehringer Ingelheim Investigational Site
Detroit, Michigan Glioma
|
Saint John Hospital and Medical Center
Detroit, Michigan 48236 Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
Wayne State University - University Health Center
Detroit, Michigan 48201 Primary Progressive Multiple Sclerosis
|
Wayne State University
Detroit, Michigan 48202 Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
|
Wayne State University
Trial Locations Wayne State University Saint John Hospital and Medical Center Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
Karmanos Cancer Institute Div.of Hematology/Oncology
Detroit, Michigan 48201 Classical Hodgkin's Lymphoma (i.e. Nodular Sclerosing, Mixed-cellularity, Lymphocyte-rich, Lymphocyte-depleted)
|
Site Reference ID/Investigator# 63592
Detroit, Michigan 48201 Hematologic Cancer
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Non-Small Cell Lung Cancer, Prostate Cancer, Pancreatic Cancer
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Adult Solid Tumor, Protocol Specific
|
Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan 48202 Lung Cancer
|
Wayne State University/Childrens' Hospital
Detroit, Michigan 48201 Graft vs Host Disease, Graft-Versus-Host Disease
|
Karmanos Cancer Institue
Detroit, Michigan 48201 Pancreatic Carcinoma Non-resectable, Metastatic Pancreatic Cancer
|
Barbara Ann Karmanos Cancer Center
Detroit, Michigan 48201 Small Cell Lung Cancer, Ovarian Cancer, Solid Tumors
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Malignant Mesothelioma
|
Wayne State University
Trial Locations Wayne State University Saint John Hospital and Medical Center Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|